Evogene Ltd.
- EVGN
- NASDAQ
- Biotechnology
- Computational Biology (AI)
- Agriculture & Human Health
$0.37
Today −4.71%Quote Oct 19, 2026, 08:00 PM UTC
−26.25%over the last month
Max drawdown −26.3%From 1-month high −26.3%3 months −30.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Evogene
Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
52
Market value
$3.2M
Quote Oct 19
Analyst target
$2.15
+484.2% from here
Floor
$0.37
0.1% below price
Resistance
$0.39
5.7% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about EVGNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free